Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001646382-25-000009
Filing Date
2025-10-22
Accepted
2025-10-22 21:05:15
Documents
1
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 form4-10222025_091011.html 4  
1 form4-10222025_091011.xml 4 4039
  Complete submission text file 0001646382-25-000009.txt   5515
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 13011 MCCALLEN PASS BUILDING A, SUITE 100 AUSTIN TX 78753
Business Address
Rabinowitz Matthew (Reporting) CIK: 0001646382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37478 | Film No.: 251411220